The True Blue Expo, held in March 2019, is the University of Toronto’s annual showcase of all things entrepreneurship and the capstone event of U of T Entrepreneurship Week. It was a great event and we are pleased that LAB150 garnered a lot of attention. Here’s…
News
Two New Projects: Cystic Fibrosis and Respiratory Syncytial Virus
Toronto, ON, Feb. 27, 2019 (GLOBE NEWSWIRE) — MaRS Innovation announced today the concurrent launch of two new LAB150 projects. These projects build on breakthroughs in disease-focused scientific research by prominent teams at The Hospital for Sick Children (SickKids) and the University of Toronto, both…
Second Project: Glaucoma Research from UHN
Toronto, ON, Oct. 04, 2018 (GLOBE NEWSWIRE) — MaRS Innovation announced today the second project to be developed under their LAB150 partnership with Evotec. The project aims to develop a novel therapeutic approach to treat glaucoma, an irreversible neurodegenerative disease of the optic nerve which…
First Project Announced!
Hamburg, Germany, and Toronto, Canada, Feb. 15, 2018 (GLOBE NEWSWIRE) — Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and MaRS Innovation announced today that they have identified the first project to be developed under their LAB150 partnership. After signing a collaboration agreement in…
A New Paradigm in Drug Discovery
The initiative, launched by MaRS Innovation and Evotec AG in September 2017, seeks to bridge academic research, translation and commercialization. Authors: Rafi Hofstein, President and CEO of MaRS Innovation, and Werner Lanthaler, President and CEO of Evotec AG. Published by Global University Venturing December 2017.…
MaRS Innovation and Evotec AG Establish Academic Bridge “LAB150” In Toronto
Toronto, Sept. 14, 2017 (GLOBE NEWSWIRE) — MaRS Innovation (“MI”) and Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced the launch of “LAB150”. This transformational Toronto-based partnership will give Canada access to the world-class infrastructure and drug discovery expertise of Evotec, and…